156 related articles for article (PubMed ID: 36263167)
1. Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liao B; Liu Z
Int J Biol Sci; 2022; 18(15):5963-5977. PubMed ID: 36263167
[TBL] [Abstract][Full Text] [Related]
2. Low expression of NTF3 is associated with unfavorable prognosis in hepatocellular carcinoma.
Yang QX; Liu T; Yang JL; Liu F; Chang L; Che GL; Lai SY; Jiang YM
Int J Clin Exp Pathol; 2020; 13(9):2280-2288. PubMed ID: 33042332
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death.
Costantini C; Rossi F; Formaggio E; Bernardoni R; Cecconi D; Della-Bianca V
J Mol Neurosci; 2005; 25(2):141-56. PubMed ID: 15784962
[TBL] [Abstract][Full Text] [Related]
4. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways.
Chen X; Ma W; Yao Y; Zhang Q; Li J; Wu X; Mei C; Jiang X; Chen Y; Wang G; Wang K; Liu Y; Guo Y; Liu Z; Yuan Y
Cell Death Dis; 2021 Apr; 12(5):425. PubMed ID: 33931585
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic impact of NTF3 and TrkC in hepatocellular carcinoma.
Wang H; Zhong C; Qi L; Fang X; Yuan Y
Scand J Gastroenterol; 2023; 58(11):1309-1316. PubMed ID: 37272057
[TBL] [Abstract][Full Text] [Related]
6. Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells.
Khwaja FS; Quann EJ; Pattabiraman N; Wynne S; Djakiew D
Mol Cancer Ther; 2008 Nov; 7(11):3539-45. PubMed ID: 18974393
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells.
Yuanlong H; Haifeng J; Xiaoyin Z; Jialin S; Jie L; Li Y; Huahong X; Jiugang S; Yanglin P; Kaichun W; Jie D; Daiming F
Cancer Lett; 2008 Sep; 268(1):110-9. PubMed ID: 18462868
[TBL] [Abstract][Full Text] [Related]
8. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
9. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma.
Zhang GP; Yue X; Li SQ
Cancer Res Treat; 2020 Jan; 52(1):10-23. PubMed ID: 31048666
[TBL] [Abstract][Full Text] [Related]
11. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
[TBL] [Abstract][Full Text] [Related]
12. p75 Neurotrophin Receptor Signaling Activates Sterol Regulatory Element-binding Protein-2 in Hepatocyte Cells via p38 Mitogen-activated Protein Kinase and Caspase-3.
Pham DD; Do HT; Bruelle C; Kukkonen JP; Eriksson O; Mogollón I; Korhonen LT; Arumäe U; Lindholm D
J Biol Chem; 2016 May; 291(20):10747-58. PubMed ID: 26984409
[TBL] [Abstract][Full Text] [Related]
13. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.
Wu CH; Hsu FT; Chao TL; Lee YH; Kuo YC
Biomed Pharmacother; 2022 Jan; 145():112437. PubMed ID: 34864311
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
15. Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma.
Zhou Y; Wu PW; Yuan XW; Li J; Shi XL
Eur Rev Med Pharmacol Sci; 2016; 20(2):250-63. PubMed ID: 26875893
[TBL] [Abstract][Full Text] [Related]
16. A new xanthatin analogue 1β-hydroxyl-5α-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma.
Fang XY; Zhang H; Zhao L; Tan S; Ren QC; Wang L; Shen XF
Biochimie; 2018 Sep; 152():43-52. PubMed ID: 29960031
[TBL] [Abstract][Full Text] [Related]
17. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
18. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
Sutter AP; Maaser K; Höpfner M; Huether A; Schuppan D; Scherübl H
J Hepatol; 2005 Nov; 43(5):808-16. PubMed ID: 16083991
[TBL] [Abstract][Full Text] [Related]
20. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.
Li Y; Xiong H
BMC Cancer; 2022 Mar; 22(1):298. PubMed ID: 35313850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
